SAT-447 PER TREATMENT POST-HOC ANALYSIS OF CLINICAL TRIAL...

Kidney International Reports 2020 / 03 Vol. 5; Iss. 3

SAT-447 PER TREATMENT POST-HOC ANALYSIS OF CLINICAL TRIAL OUTCOMES WITH TOLVAPTAN (TLV) IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

Mallett, A., Perrone, R., Rangan, G., Hawley, C., El-Damanawi, R., Hiemstra, T.F., Townsend Arellano, C., Lee, J., Torres, V.E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Journal:
Kidney International Reports
DOI:
10.1016/j.ekir.2020.02.474
Date:
March, 2020
File:
PDF, 276 KB
2020
Conversion to is in progress
Conversion to is failed